Early evaluation of response to neoadjuvant treatment: FDG-PET/CT criteria according to breast cancer subtype

被引：0
|
作者：
Groheux, David [1 ]
Majdoub, Mohamed [2 ]
de Cremoux, Patricia [1 ]
Hindie, Elif [3 ]
Martineau, Antoine [1 ]
Merlet, Pascal [1 ]
Visvikis, Dimitris [2 ]
Hatt, Mathieu [2 ]
Espie, Marc [1 ]
机构：
[1] Hop St Louis, Paris, France
[2] INSERM, LaTIM, UMR 1101, Brest, France
[3] CHU Bordeaux, Bordeaux, France
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
286
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer Subtype
    Groheux, David
    Majdoub, Mohamed
    Sanna, Alice
    de Cremoux, Patricia
    Hindie, Elif
    Giacchetti, Sylvie
    Martineau, Antoine
    de Roquancourt, Anne
    Merlet, Pascal
    Visvikis, Dimitris
    Resche-Rigon, Matthieu
    Hatt, Mathieu
    Espie, Marc
    RADIOLOGY, 2015, 277 (02) : 358 - 371
  • [2] Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer?
    Andrade, W. P.
    Lima, E. N. P.
    Osorio, C. A. B. T.
    do Socorro Maciel, M.
    Baiocchi, G.
    Bitencourt, A. G. V.
    Fanelli, M. F.
    Damascena, A. S.
    Soares, F. A.
    EJSO, 2013, 39 (12): : 1358 - 1363
  • [3] Breast cancer: treatment response assessment with FDG-PET/CT in the neoadjuvant and in the metastatic setting
    David Groheux
    Gary A. Ulaner
    Elif Hindie
    Clinical and Translational Imaging, 2023, 11 : 439 - 452
  • [4] Breast cancer: treatment response assessment with FDG-PET/CT in the neoadjuvant and in the metastatic setting
    Groheux, David
    Ulaner, Gary A.
    Hindie, Elif
    CLINICAL AND TRANSLATIONAL IMAGING, 2023, 11 (05) : 439 - 452
  • [5] Utility of FDG-PET/CT in the Evaluation of the Response of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy
    Ogino, Kei
    Nakajima, Masanobu
    Kakuta, Miyako
    Hayashi, Mitsuhiro
    Yamaguchi, Satoru
    Tsuchioka, Takashi
    Kubota, Keiichi
    Sakamoto, Setsu
    Kato, Hiroyuki
    INTERNATIONAL SURGERY, 2014, 99 (04) : 309 - 318
  • [6] Assessment of clinicopathological subtype of breast cancer by FDG-PET/CT
    Miyake, K. K.
    Nakamoto, Y.
    Kanao, S.
    Tanaka, S.
    Togashi, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S283 - S283
  • [7] FDG-PET/CT for predicting pathologic response of locally advanced breast cancer to neoadjuvant therapy: influence of receptor subtype
    Williams, Jason
    Arlinghaus, Lori
    Li, Xia
    Pendyala, Praveen
    Abramson, Richard
    Abramson, Vandana
    Chakravarthy, A. Bapsi
    Yankeelov, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [8] A role of FDG-PET/CT for response evaluation in metastatic breast cancer?
    Hildebrandt, Malene Grubbe
    Naghavi-Behzad, Mohammad
    Vogsen, Marianne
    SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (05) : 520 - 530
  • [9] Predictive value of FDG-PET/CT after neoadjuvant endocrine treatment in breast cancer
    Boughdad, S.
    Champion, L.
    Becette, V.
    Cherel, P.
    Fourme, E.
    Edeline, V.
    Lemonnier, J.
    Lerebours, F.
    Alberini, J. L.
    CANCER RESEARCH, 2017, 77
  • [10] FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy
    van de Putte, E. E. Fransen
    Vegt, E.
    Mertens, L. S.
    Bruining, A.
    Hendricksen, K.
    van der Heijden, M. S.
    Horenblas, S.
    van Rhijn, B. W. G.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (09) : 1585 - 1591
12345